🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-h...
Status
Completed
Location
HLB Science
Start Date
2023-07-24
Trial ID
NCT07347223
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Quotient Clinical
Start Date
2013-08
Trial ID
NCT01918735
This study aims to evaluate the safety, tolerability and pharmacodynamics o...
Status
Completed
Location
The First Affiliated Hospital Of USTC
Start Date
2023-02-17
Trial ID
NCT05681819
Treatments Being Tested
The investigational product, named Ovasave (Ova-Treg), is a cell-based ther...
Status
Terminated
Location
Medical University Innsbruck
Start Date
2014-12
Trial ID
NCT02327221
1. Part 1 Randimization, Double blinded, Placebo controlled, Dose escalatio...
Status
Completed
Location
Seoul National University
Start Date
2022-05-13
Trial ID
NCT05389696
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
Syneos Health
Start Date
2023-11-22
Trial ID
NCT06181786
The purpose of this study is to evaluate the efficacy and safety of NRX-107...
Status
Completed
Location
Pacific Research Partners
Start Date
2014-03
Trial ID
NCT02067793
Treatments Being Tested
This study aims to assess the safety of ARGX-213 in healthy adults. Another...
Status
Completed
Location
Altasciences
Start Date
2025-04-11
Trial ID
NCT06968338
The purpose of this First-in-Human study is to evaluate the safety , tolera...
Status
Completed
Location
Paolo B. DePetrillo
Start Date
2018-11-09
Trial ID
NCT03740555